Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SCHOTT to Strengthen Pharmaceutical Site in Hungary

Published: Monday, June 10, 2013
Last Updated: Sunday, June 09, 2013
Bookmark and Share
New maintenance facility will be opened in the Lukácsháza region.

SCHOTT Pharmaceutical Systems has announced plans to significantly expand its Hungarian site Lukácsháza that manufactures pharmaceutical primary packaging.

Investments in the mid-double-digit million euro range are planned from now until 2016.

The first step will be to open a new maintenance facility for overhauling and upgrading production machines that will create more than 30 new jobs in the Lukácsháza region.

In addition, production capacity should continue to increase in Hungary over the next few years.

SCHOTT manufactures ampoules, vials, and cartridges or so-called primary packaging for the pharmaceutical industry at its site in Lukácsháza near the Hungarian-Austrian border. The plant has continued to grow since it first opened in 1993.

Today, Lukácsháza, with its roughly 530 employees and annual production of more than 1.7 billion units, is the SCHOTT Pharmaceutical Division's single largest site.

The products manufactured in Lukácsháza are mainly exported to all parts of Europe and overseas, but also produced for the local market.

In addition to opening this global maintenance center, SCHOTT has also established a team of experts at this site that will overhaul its production machines on a regular basis and upgrade them to meet the latest technical standards.

“By doing so, we actively demonstrate our commitment to living up to the highest standards for quality and maintaining these over the long-term, in fact even for all of our global plants,” explains Dr. Jürgen Sackhoff, Vice President of SCHOTT Pharmaceutical Systems.

For Dr. Frank Heinricht, Chairman of the Board of Management, the expansion of the site in Hungary is only part of what can be considered a global investment strategy. After all, SCHOTT also intends to install new production lines in Hungary over time.

“On average, our annual production of ampoules, cartridges and vials will increase by almost half at this site,” Heinricht says and adds, “With our investment strategy, we will be helping our customers around the world to meet their quality and growth targets.”

The company also opened a new plant in India just recently and significantly expanded its capacities in Indonesia and Russia. A new joint venture in China also further expands its global manufacturing network.

Strong base in the region

SCHOTT’s expansion in Hungary also sends a powerful message to the Lukácsháza region. “We are aware of our importance as a local employer,” explains Christoph Döppes, Managing Director of the site in Lukácsháza.

“Our commitment here is long-term in nature and we are working together with the local authorities on further developing this site,” he adds.

Besides opening its new machine building facility, which received public funding support, and expanding its production capacities, SCHOTT also plans to create a number of new skilled jobs for machine builders, technicians and engineers, for instance.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCHOTT Committed to Further Investments in Brazilian Pharma Packaging Plant
Celebrating 80 years of ampoule manufacturing in Brazil.
Thursday, April 23, 2015
A Thousandfold Boost in Glass Knowledge Helps Pharma Industry to Better Package Drugs
SCHOTT trained more than 3,000 pharma professionals through the FIOLAX Academy, supporting the industry to increase patient safety.
Wednesday, March 25, 2015
SCHOTT Announces Major Expansion of Pharmaceutical Packaging Manufacturing in Russia
Capacity to expand by more than 50 percent / Consistent investment strategy helps customers achieve growth and quality objectives.
Monday, November 26, 2012
Schott Looks to KNF Flodos for Pump Technology
Schott uses KNF Flodos’ Pumps in the development of analytical instruments.
Monday, May 29, 2006
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!